Sensitivity of rapid antigen tests for Omicron subvariants of SARS‐CoV‐2
Diagnosis by rapid antigen tests (RATs) is useful for early initiation of antiviral treatment. Because RATs are easy to use, they can be adapted for self‐testing. Several kinds of RATs approved for such use by the Japanese regulatory authority are available from drug stores and websites. Most RATs f...
Saved in:
Published in | Journal of medical virology Vol. 95; no. 5; pp. e28788 - n/a |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.05.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Diagnosis by rapid antigen tests (RATs) is useful for early initiation of antiviral treatment. Because RATs are easy to use, they can be adapted for self‐testing. Several kinds of RATs approved for such use by the Japanese regulatory authority are available from drug stores and websites. Most RATs for COVID‐19 are based on antibody detection of the SARS‐CoV‐2 N protein. Since Omicron and its subvariants have accumulated several amino acid substitutions in the N protein, such amino acid changes might affect the sensitivity of RATs. Here, we investigated the sensitivity of seven RATs available in Japan, six of which are approved for public use and one of which is approved for clinical use, for the detection of BA.5, BA.2.75, BF.7, XBB.1, and BQ.1.1, as well as the delta variant (B.1.627.2). All tested RATs detected the delta variant with a detection level between 7500 and 75 000 pfu per test, and all tested RATs showed similar sensitivity to the Omicron variant and its subvariants (BA.5, BA.2.75, BF.7, XBB.1, and BQ.1.1). Human saliva did not reduce the sensitivity of the RATs tested. Espline SARS‐CoV‐2 N showed the highest sensitivity followed by Inspecter KOWA SARS‐CoV‐2 and V Trust SARS‐CoV‐2 Ag. Since the RATs failed to detect low levels of infectious virus, individuals whose specimens contained less infectious virus than the detection limit would be considered negative. Therefore, it is important to note that RATs may miss individuals shedding low levels of infectious virus. |
---|---|
AbstractList | Diagnosis by rapid antigen tests (RATs) is useful for early initiation of antiviral treatment. Because RATs are easy to use, they can be adapted for self-testing. Several kinds of RATs approved for such use by the Japanese regulatory authority are available from drug stores and websites. Most RATs for COVID-19 are based on antibody detection of the SARS-CoV-2 N protein. Since Omicron and its subvariants have accumulated several amino acid substitutions in the N protein, such amino acid changes might affect the sensitivity of RATs. Here, we investigated the sensitivity of seven RATs available in Japan, six of which are approved for public use and one of which is approved for clinical use, for the detection of BA.5, BA.2.75, BF.7, XBB.1, and BQ.1.1, as well as the delta variant (B.1.627.2). All tested RATs detected the delta variant with a detection level between 7500 and 75 000 pfu per test, and all tested RATs showed similar sensitivity to the Omicron variant and its subvariants (BA.5, BA.2.75, BF.7, XBB.1, and BQ.1.1). Human saliva did not reduce the sensitivity of the RATs tested. Espline SARS-CoV-2 N showed the highest sensitivity followed by Inspecter KOWA SARS-CoV-2 and V Trust SARS-CoV-2 Ag. Since the RATs failed to detect low levels of infectious virus, individuals whose specimens contained less infectious virus than the detection limit would be considered negative. Therefore, it is important to note that RATs may miss individuals shedding low levels of infectious virus.Diagnosis by rapid antigen tests (RATs) is useful for early initiation of antiviral treatment. Because RATs are easy to use, they can be adapted for self-testing. Several kinds of RATs approved for such use by the Japanese regulatory authority are available from drug stores and websites. Most RATs for COVID-19 are based on antibody detection of the SARS-CoV-2 N protein. Since Omicron and its subvariants have accumulated several amino acid substitutions in the N protein, such amino acid changes might affect the sensitivity of RATs. Here, we investigated the sensitivity of seven RATs available in Japan, six of which are approved for public use and one of which is approved for clinical use, for the detection of BA.5, BA.2.75, BF.7, XBB.1, and BQ.1.1, as well as the delta variant (B.1.627.2). All tested RATs detected the delta variant with a detection level between 7500 and 75 000 pfu per test, and all tested RATs showed similar sensitivity to the Omicron variant and its subvariants (BA.5, BA.2.75, BF.7, XBB.1, and BQ.1.1). Human saliva did not reduce the sensitivity of the RATs tested. Espline SARS-CoV-2 N showed the highest sensitivity followed by Inspecter KOWA SARS-CoV-2 and V Trust SARS-CoV-2 Ag. Since the RATs failed to detect low levels of infectious virus, individuals whose specimens contained less infectious virus than the detection limit would be considered negative. Therefore, it is important to note that RATs may miss individuals shedding low levels of infectious virus. Diagnosis by rapid antigen tests (RATs) is useful for early initiation of antiviral treatment. Because RATs are easy to use, they can be adapted for self‐testing. Several kinds of RATs approved for such use by the Japanese regulatory authority are available from drug stores and websites. Most RATs for COVID‐19 are based on antibody detection of the SARS‐CoV‐2 N protein. Since Omicron and its subvariants have accumulated several amino acid substitutions in the N protein, such amino acid changes might affect the sensitivity of RATs. Here, we investigated the sensitivity of seven RATs available in Japan, six of which are approved for public use and one of which is approved for clinical use, for the detection of BA.5, BA.2.75, BF.7, XBB.1, and BQ.1.1, as well as the delta variant (B.1.627.2). All tested RATs detected the delta variant with a detection level between 7500 and 75 000 pfu per test, and all tested RATs showed similar sensitivity to the Omicron variant and its subvariants (BA.5, BA.2.75, BF.7, XBB.1, and BQ.1.1). Human saliva did not reduce the sensitivity of the RATs tested. Espline SARS‐CoV‐2 N showed the highest sensitivity followed by Inspecter KOWA SARS‐CoV‐2 and V Trust SARS‐CoV‐2 Ag. Since the RATs failed to detect low levels of infectious virus, individuals whose specimens contained less infectious virus than the detection limit would be considered negative. Therefore, it is important to note that RATs may miss individuals shedding low levels of infectious virus. |
Author | Sakai‐Tagawa, Yuko Bobholz, Max Wei, Wanting Yamayoshi, Seiya Halfmann, Peter J. Bakel, Harm Sordillo, Emilia M. Ries, Hunter Kawaoka, Yoshihiro Wilson, Nancy O'Connor, David H. Vuyk, William C. Friedrich, Thomas C. Simon, Viviana |
Author_xml | – sequence: 1 givenname: Yuko surname: Sakai‐Tagawa fullname: Sakai‐Tagawa, Yuko organization: University of Tokyo – sequence: 2 givenname: Seiya orcidid: 0000-0001-7768-5157 surname: Yamayoshi fullname: Yamayoshi, Seiya email: yamayo@ims.u-tokyo.ac.jp organization: National Center for Global Health and Medicine Research Institute – sequence: 3 givenname: Peter J. surname: Halfmann fullname: Halfmann, Peter J. organization: University of Wisconsin‐Madison – sequence: 4 givenname: Nancy surname: Wilson fullname: Wilson, Nancy organization: University of Wisconsin – sequence: 5 givenname: Max surname: Bobholz fullname: Bobholz, Max organization: University of Wisconsin – sequence: 6 givenname: William C. surname: Vuyk fullname: Vuyk, William C. organization: University of Wisconsin – sequence: 7 givenname: Wanting surname: Wei fullname: Wei, Wanting organization: University of Wisconsin‐Madison – sequence: 8 givenname: Hunter surname: Ries fullname: Ries, Hunter organization: University of Wisconsin‐Madison – sequence: 9 givenname: David H. surname: O'Connor fullname: O'Connor, David H. organization: University of Wisconsin – sequence: 10 givenname: Thomas C. surname: Friedrich fullname: Friedrich, Thomas C. organization: University of Wisconsin – sequence: 11 givenname: Emilia M. surname: Sordillo fullname: Sordillo, Emilia M. organization: Icahn School of Medicine at Mount Sinai – sequence: 12 givenname: Harm surname: Bakel fullname: Bakel, Harm organization: Icahn School of Medicine at Mount Sinai – sequence: 13 givenname: Viviana surname: Simon fullname: Simon, Viviana organization: Icahn School of Medicine at Mount Sinai – sequence: 14 givenname: Yoshihiro surname: Kawaoka fullname: Kawaoka, Yoshihiro email: yoshihiro.kawaoka@wisc.edu organization: The University of Tokyo Pandemic Preparedness |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37212288$$D View this record in MEDLINE/PubMed |
BookMark | eNp90b1OwzAQB3ALgaAFBl4ARWKBIXB2ncQeUcWnipAosEZO7CBXiV3spKgbj8Az8iS4tDBUAg_n5Xen0_37aNNYoxA6wHCKAcjZpJmdEpYxtoF6GHgac8jwJuoBpmmcpjjZQX3vJwDAOCHbaGeQEUwIYz00Givjdatnup1HtoqcmGoZCdPqF2WiVvnWR5V10X2jS2dN5LtiJpwOwC_4-Pxh_Pn-MbTPoZI9tFWJ2qv91b-Lni4vHofX8ej-6mZ4PopLmlAWU5UBKyVISiuS0oIzroTMBBMKAMOApRykxEWZEpYwmkmeKlUmBCQfVLioBrvoeDl36uxrF3bMG-1LVdfCKNv5nDCchUcAB3q0Rie2cyZst1A8oZTQhTpcqa5olMynTjfCzfOfOwVwsgThCN47Vf0SDPkigzxkkH9nEOzZmi11K1ptTeuErv_reNO1mv89Or-9e152fAFYdpfN |
CitedBy_id | crossref_primary_10_1371_journal_pone_0289990 crossref_primary_10_1186_s12879_024_09408_8 crossref_primary_10_11124_JBIES_23_00291 crossref_primary_10_1016_j_heliyon_2024_e29937 crossref_primary_10_1128_spectrum_01768_23 crossref_primary_10_1002_jmv_29361 |
Cites_doi | 10.1007/s00430-022-00752-7 10.1016/j.jviromet.2020.114024 10.3390/v14040654 10.1128/spectrum.02286-22 10.1007/s00430-021-00719-0 10.1016/j.jcv.2020.104472 10.1128/JCM.01438-20 10.1128/JCM.00977-20 10.1002/jmv.27908 10.1371/journal.pone.0239403 10.1016/j.jiac.2021.01.007 10.3390/life12111941 10.1007/s00430-022-00730-z 10.1001/jamanetworkopen.2022.35844 10.1016/j.ijid.2020.05.098 10.1001/jama.2020.8259 10.1016/j.jcv.2020.104455 10.3390/v13112183 10.3389/fmed.2020.00225 10.2147/IJGM.S297762 10.1016/j.jcv.2020.104712 10.1016/j.jcv.2022.105119 10.1128/spectrum.01922-22 10.1016/j.jcv.2020.104500 10.3390/v12121420 |
ContentType | Journal Article |
Copyright | 2023 The Authors. published by Wiley Periodicals LLC. 2023 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC. 2023. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2023 The Authors. published by Wiley Periodicals LLC. – notice: 2023 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC. – notice: 2023. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QL 7TK 7U9 8FD C1K FR3 H94 K9. M7N P64 RC3 7X8 |
DOI | 10.1002/jmv.28788 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Bacteriology Abstracts (Microbiology B) Neurosciences Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Virology and AIDS Abstracts Technology Research Database Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Genetics Abstracts MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1096-9071 |
EndPage | n/a |
ExternalDocumentID | 37212288 10_1002_jmv_28788 JMV28788 |
Genre | shortCommunication Research Support, U.S. Gov't, P.H.S Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: Centers for Disease Control and Prevention – fundername: Japan Agency for Medical Research and Development – fundername: State of Wisconsin Department of Health Services project – fundername: National Institutes of Allergy and Infectious Diseases Center for Research – fundername: CDC HHS – fundername: NIH HHS grantid: S10 OD030463 – fundername: NIH HHS grantid: S10 OD026880 |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 24P 31~ 33P 3O- 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFFNX AFFPM AFGKR AFRAH AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHMBA AI. AIACR AIDQK AIDYY AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS ECGQY EJD ELTNK EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M65 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RX1 RYL SAMSI SUPJJ SV3 TEORI TUS UB1 V2E VH1 W8V W99 WBKPD WHG WIB WIH WIJ WIK WJL WNSPC WOHZO WQJ WXI WXSBR WYISQ X7M XG1 XPP XV2 ZGI ZXP ZZTAW ~IA ~KM ~WT AAHHS AAYXX ACCFJ AEEZP AEQDE AIWBW AJBDE CITATION CGR CUY CVF ECM EIF NPM 7QL 7TK 7U9 8FD C1K FR3 H94 K9. M7N P64 RC3 7X8 |
ID | FETCH-LOGICAL-c4548-4e708cd0d44f264b989ead7a8ae001038690dd1bc6285847d96eec520d93f1bf3 |
IEDL.DBID | DR2 |
ISSN | 0146-6615 1096-9071 |
IngestDate | Thu Jul 10 23:18:45 EDT 2025 Fri Jul 25 21:34:56 EDT 2025 Mon Jul 21 06:03:35 EDT 2025 Tue Jul 01 02:24:59 EDT 2025 Thu Apr 24 23:10:56 EDT 2025 Sun Jul 06 04:45:01 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | SARS-CoV-2 Sensitivity Omicron Rapid antigen test |
Language | English |
License | Attribution-NonCommercial 2023 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4548-4e708cd0d44f264b989ead7a8ae001038690dd1bc6285847d96eec520d93f1bf3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-7768-5157 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmv.28788 |
PMID | 37212288 |
PQID | 2819544241 |
PQPubID | 105515 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_2817777201 proquest_journals_2819544241 pubmed_primary_37212288 crossref_primary_10_1002_jmv_28788 crossref_citationtrail_10_1002_jmv_28788 wiley_primary_10_1002_jmv_28788_JMV28788 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | May 2023 2023-05-00 20230501 |
PublicationDateYYYYMMDD | 2023-05-01 |
PublicationDate_xml | – month: 05 year: 2023 text: May 2023 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: London |
PublicationTitle | Journal of medical virology |
PublicationTitleAlternate | J Med Virol |
PublicationYear | 2023 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2021; 14 2020; 7 2021; 13 2022; 211 2021; 27 2023; 11 2021; 288 2021; 134 2022; 5 2022; 94 2023; 212 2022; 12 2022; 14 2020; 15 2020; 58 2020; 129 2020; 12 2020; 323 2020; 99 2021; 210 2022; 10 2022; 148 e_1_2_9_11_1 e_1_2_9_10_1 e_1_2_9_13_1 e_1_2_9_12_1 e_1_2_9_15_1 e_1_2_9_14_1 e_1_2_9_17_1 e_1_2_9_16_1 e_1_2_9_19_1 e_1_2_9_18_1 e_1_2_9_20_1 e_1_2_9_22_1 e_1_2_9_21_1 e_1_2_9_24_1 e_1_2_9_23_1 e_1_2_9_8_1 e_1_2_9_7_1 e_1_2_9_6_1 e_1_2_9_5_1 e_1_2_9_4_1 e_1_2_9_3_1 e_1_2_9_2_1 e_1_2_9_9_1 e_1_2_9_26_1 e_1_2_9_25_1 |
References_xml | – volume: 58 issue: 9 year: 2020 article-title: Clinical evaluation of self‐collected saliva by quantitative reverse transcription‐PCR (RT‐qPCR), direct RT‐qPCR, reverse transcription‐loop‐mediated isothermal amplification, and a rapid antigen test to diagnose COVID‐19 publication-title: J Clin Microbiol – volume: 14 issue: 4 year: 2022 article-title: Analytical sensitivity of six SARS‐CoV‐2 rapid antigen tests for omicron versus Delta variant publication-title: Viruses – volume: 10 issue: 5 year: 2022 article-title: Decreased sensitivity of rapid antigen test is associated with a lower viral load of omicron than delta SARS‐CoV‐2 variant publication-title: Microbiol Spectr – volume: 323 start-page: 2249 issue: 22 year: 2020 end-page: 2251 article-title: Interpreting diagnostic tests for SARS‐CoV‐2 publication-title: JAMA – volume: 27 start-page: 800 issue: 6 year: 2021 end-page: 807 article-title: Evaluating a novel, highly sensitive, and quantitative reagent for detecting SARS‐CoV‐2 antigen publication-title: J Infect Chemother – volume: 7 year: 2020 article-title: Development and potential usefulness of the COVID‐19 Ag Respi‐Strip diagnostic assay in a pandemic context publication-title: Front Med – volume: 288 year: 2021 article-title: Comparison of the SARS‐CoV‐2 Rapid antigen test to the real star Sars‐CoV‐2 RT PCR kit publication-title: J Virol Methods – volume: 148 year: 2022 article-title: Determining the reliability of rapid SARS‐CoV‐2 antigen detection in fully vaccinated individuals publication-title: J Clin Virol – volume: 129 year: 2020 article-title: Implementation of rapid SARS‐CoV‐2 antigenic testing in a laboratory without access to molecular methods: experiences of a general hospital publication-title: J Clin Virol – volume: 211 start-page: 105 issue: 2‐3 year: 2022 end-page: 117 article-title: Impaired detection of omicron by SARS‐CoV‐2 rapid antigen tests publication-title: Med Microbiol Immunol – volume: 99 start-page: 328 year: 2020 end-page: 333 article-title: Evaluation of a novel antigen‐based rapid detection test for the diagnosis of SARS‐CoV‐2 in respiratory samples publication-title: Int J Infect Dis – volume: 134 year: 2021 article-title: Evaluation of rapid antigen detection kit from the WHO Emergency Use List for detecting SARS‐CoV‐2 publication-title: J Clin Virol – volume: 15 issue: 9 year: 2020 article-title: Disentangling primer interactions improves SARS‐CoV‐2 genome sequencing by multiplex tiling PCR publication-title: PLoS One – volume: 210 start-page: 263 year: 2021 end-page: 275 article-title: Comparison of four commercial, automated antigen tests to detect SARS‐CoV‐2 variants of concern publication-title: Med Microbiol Immunol – volume: 129 year: 2020 article-title: Evaluation of rapid antigen test for detection of SARS‐CoV‐2 virus publication-title: J Clin Virol – volume: 212 start-page: 13 issue: 1 year: 2023 end-page: 23 article-title: Variable detection of Omicron‐BA.1 and ‐BA.2 by SARS‐CoV‐2 rapid antigen tests publication-title: Med Microbiol Immunol – volume: 58 issue: 8 year: 2020 article-title: Evaluation of a rapid diagnostic assay for detection of SARS‐CoV‐2 antigen in nasopharyngeal swabs publication-title: J Clin Microbiol – volume: 14 start-page: 435 year: 2021 end-page: 440 article-title: Evaluation of analytical performance of seven rapid antigen detection kits for detection of SARS‐CoV‐2 virus publication-title: Int J Gen Med – volume: 129 year: 2020 article-title: Low performance of rapid antigen detection test as frontline testing for COVID‐19 diagnosis publication-title: J Clin Virol – volume: 13 issue: 11 year: 2021 article-title: Comparative sensitivity of rapid antigen tests for the delta variant (B.1.617.2) of SARS‐CoV‐2 publication-title: Viruses – volume: 94 start-page: 5033 issue: 10 year: 2022 end-page: 5037 article-title: Analytical sensitivity of the Rapid Antigen Test kits for detection of SARS‐CoV‐2 Omicron variant BA.2 sublineage publication-title: J Med Virol – volume: 12 issue: 11 year: 2022 article-title: The performance of lateral flow tests in the age of the omicron: a rapid systematic review publication-title: Life – volume: 11 issue: 1 year: 2023 article-title: Performance evaluation of five rapid at‐home COVID‐19 antigen tests against the omicron variant publication-title: Microbiol Spectr – volume: 12 start-page: 1420 issue: 12 year: 2020 article-title: Comparison of rapid antigen tests for COVID‐19 publication-title: Viruses – volume: 5 issue: 10 year: 2022 article-title: COVID‐19 symptoms and duration of rapid antigen test positivity at a community testing and surveillance site during pre‐delta, delta, and omicron BA.1 periods publication-title: JAMA Netw Open – ident: e_1_2_9_20_1 doi: 10.1007/s00430-022-00752-7 – ident: e_1_2_9_12_1 doi: 10.1016/j.jviromet.2020.114024 – ident: e_1_2_9_24_1 doi: 10.3390/v14040654 – ident: e_1_2_9_22_1 doi: 10.1128/spectrum.02286-22 – ident: e_1_2_9_15_1 doi: 10.1007/s00430-021-00719-0 – ident: e_1_2_9_9_1 doi: 10.1016/j.jcv.2020.104472 – ident: e_1_2_9_3_1 doi: 10.1128/JCM.01438-20 – ident: e_1_2_9_5_1 doi: 10.1128/JCM.00977-20 – ident: e_1_2_9_19_1 doi: 10.1002/jmv.27908 – ident: e_1_2_9_26_1 doi: 10.1371/journal.pone.0239403 – ident: e_1_2_9_13_1 doi: 10.1016/j.jiac.2021.01.007 – ident: e_1_2_9_17_1 doi: 10.3390/life12111941 – ident: e_1_2_9_21_1 doi: 10.1007/s00430-022-00730-z – ident: e_1_2_9_18_1 doi: 10.1001/jamanetworkopen.2022.35844 – ident: e_1_2_9_6_1 doi: 10.1016/j.ijid.2020.05.098 – ident: e_1_2_9_2_1 doi: 10.1001/jama.2020.8259 – ident: e_1_2_9_7_1 doi: 10.1016/j.jcv.2020.104455 – ident: e_1_2_9_16_1 doi: 10.3390/v13112183 – ident: e_1_2_9_8_1 doi: 10.3389/fmed.2020.00225 – ident: e_1_2_9_11_1 doi: 10.2147/IJGM.S297762 – ident: e_1_2_9_14_1 doi: 10.1016/j.jcv.2020.104712 – ident: e_1_2_9_23_1 doi: 10.1016/j.jcv.2022.105119 – ident: e_1_2_9_25_1 doi: 10.1128/spectrum.01922-22 – ident: e_1_2_9_4_1 doi: 10.1016/j.jcv.2020.104500 – ident: e_1_2_9_10_1 doi: 10.3390/v12121420 |
SSID | ssj0008922 |
Score | 2.4302537 |
Snippet | Diagnosis by rapid antigen tests (RATs) is useful for early initiation of antiviral treatment. Because RATs are easy to use, they can be adapted for... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e28788 |
SubjectTerms | Amino acid sequence Amino Acid Substitution Amino acids Antibodies Antigens Antiviral Agents Antiviral drugs COVID-19 COVID-19 - diagnosis Humans N protein Omicron Proteins Rapid antigen test Regulatory agencies Saliva SARS-CoV-2 - genetics SARS‐CoV‐2 Sensitivity Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Virology Viruses Websites |
Title | Sensitivity of rapid antigen tests for Omicron subvariants of SARS‐CoV‐2 |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmv.28788 https://www.ncbi.nlm.nih.gov/pubmed/37212288 https://www.proquest.com/docview/2819544241 https://www.proquest.com/docview/2817777201 |
Volume | 95 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTtxAEC0RDiiXsCQhw6YOyoGLB7vd3sQJIRBCTIiYgDhEstyLpQDjQcwMB058At_Il1DVbRsBiYTwwbLkstvurV53Vb0C-METnSUyCL0iSLQnZMDJSGg8E-hCKRmXYUABzr2f8f6JODiLzqZgq4mFcfwQ7YYbjQw7X9MAL-Ro84k09Hxw00W4n1KgL_lqESA6fqKOSjNnQcCZwEMdFDWsQj7fbJ98roteAczneNUqnL1Z-NN8qvMzuehOxrKrbl-wOL7zX-bgUw1E2bbrOfMwZaoFmOnVpvbPcNgn13aXW4INS3ZdXP3VDNuB6DsZAtTxiCHgZUcDcumr2Ggib3DdTW41JN7fPu4_3N3vDE_xzL_Ayd7u7519r0694CkR0RajSfxUaV8LUSJkklmaYZdLirQwNjME5bHSOpCKIjBRweksNkZF3NdZWAayDL_CdDWszDdgKkPEFPgGsU4sigjfwP20TFUscKWCAKcDG00j5KrmJaf0GJe5Y1TmOdZObmunA-ut6JUj4_iX0ErTknk9Hke5NRcKgXClA9_b2ziSyDxSVGY4sTIJHoiIOrDoekBbSogLZc7p5Ru2Hf9ffH7QO7UXS28XXYaPlMXe-VGuwPT4emJWEeuM5Rp84OLXmu3aj9gw-wA |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LT9wwEB5RKrW9QN8s0NatWolLdhPHeR16QFC0wC6VWHa1txA_IpVHFrG7IDjxE_gh_JX-if6Sju0kiD6kXjg0hyhKRnZiz4y_2ONvAD7SSCYR93wn8yLpMO5RvUioHOXJTAge5r6nNzh3d8J2n20Ng-EM3FR7YSw_RD3hpi3D-Gtt4HpCunXLGnpwfNZEvB_HZUjltro4xx-28efNdezdT5RufNlbaztlTgFHsEDPnanIjYV0JWM5YgGexAm2ZZTFmTIpD3SCJik9LvTWQvTcMgmVEgF1ZeLnHs99LPcBPNQZxDVT__ruLVlVnNg1C_Q9Do56QcVj5NJW_ap3R7_fIO1dhGyGuI15-F41jo1sOWxOJ7wpLn_hjfxfWu8pzJVYm6xa43gGM6p4Do-6ZTTBC-j0dPS-TZ9BRjk5zU6-SYKqphlKCWLwyZggpidfj3XUYkHGU36WocEWeB_Fe6u7vR9X12ujAZ7pS-jfy7e8gtliVKgFICJBUOi5CuFcyLIAS6BunMciZPgzhhiuAStVr6eipF7XGUCOUksaTVPsjdT0RgM-1KInlm_kT0LLleqkpcsZp2ZFlDFEZA14Xz9GZ6FXgLJCjaZGJsIDQV8DXluVq2vxI0QxVBe-YhTn79WnW92BuVj8d9F38Li91-2knc2d7SV4QhEq2rDRZZidnE7VG4R2E_7WWBSB_ftWwp9--Fel |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT-QwDLZ4SIgLApaF4ZlFrMSl0Kbp68ABASNeA2gHELfSJqkEgs6ImQFx4yfwP_hX_BLstFOEFiQu9FBVqpVEdux8iR0bYIUHKgpSx7USJ1CWSB1OTkJtaUclUqZ-5jp0wblx5O-eif0L72IAXvp3YYr8ENWBG2mGsdek4G2Vrb8nDb2-vV9DuB-GZUTlgX58wP1aZ2NvG4X7l_P6zunWrlWWFLCk8OjoTAd2KJWthMgQCqRRGCErgyRMtKl4QPWZlHJSSTcL0XCryNdaetxWkZs5aeZiu4MwTM5Fih_j4qQy-2FUuCzQ9Fi46Hn9NEY2X6-G-nHx-w_RfgTIZoWrj8NYCU3ZZjGXJmBA55Mw0iid77_gsEnB7kW1CdbK2F3SvlIMJUMJPRlC1m6HIQRmx7cU5JezTi-9x504BdoQeXPzX_P16XmrdY5vPgVnP8K53zCUt3I9A0xGiKEcWyP68UXiYQvcDrNQ-shWgqc1WO1zKZZlpnIqmHETFzmWeYwMjQ1Da7BckbaL9ByfEc33WR2XGtqJjQNRCAQwNfhT_UbdIodJkutWz9AE-CBGqsF0IaKqFxe3zpxT46tGZl93H-83zs3H7PdJl2DkZLseH-4dHczBKJW4L4Is52Goe9fTCwiEuumimYAMLn96xr8By0QWLA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sensitivity+of+rapid+antigen+tests+for+Omicron+subvariants+of+SARS%E2%80%90CoV%E2%80%902&rft.jtitle=Journal+of+medical+virology&rft.au=Yuko+Sakai%E2%80%90Tagawa&rft.au=Yamayoshi%2C+Seiya&rft.au=Halfmann%2C+Peter+J&rft.au=Wilson%2C+Nancy&rft.date=2023-05-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0146-6615&rft.eissn=1096-9071&rft.volume=95&rft.issue=5&rft_id=info:doi/10.1002%2Fjmv.28788&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0146-6615&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0146-6615&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0146-6615&client=summon |